FRANKFURT--The following is a summary of analysts' forecasts for Sanofi SA (SNY) second-quarter results, based on a poll of nine analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released July 26.
===
Business Business
Net Oper. net Business
2nd Quarter sales Income income EPS
AVERAGE 8,686 2,676 1,876 1.42
Prev. Year 8,349 2,945 2,150 1.64
+/- in % +4.0 -9.1 -13 -13
MEDIAN 8,690 2,675 1,872 1.42
Maximum 8,836 2,772 1,926 1.46
Minimum 8,495 2,574 1,794 1.37
Amount 9 9 9 9
Bernstein 8,764 2,636 1,829 1.39
Cheuvreux 8,690 2,675 1,864 1.42
Credit Suisse 8,836 2,754 1,917 1.45
Deutsche Bank 8,697 2,580 1,794 1.37
Exane BNP Paribas 8,696 2,652 1,872 1.42
Helvea 8,661 2,693 1,898 1.44
J.P. Morgan 8,688 2,772 1,926 1.46
Natixis 8,495 2,750 1,925 1.46
Nomura 8,651 2,574 1,857 1.40
Target price Rating DPS 2012
AVERAGE 65.86 positive 6 AVERAGE 2.87
Prev. Quarter 64.60 neutral 1 Prev. Year 2.50
+/- in % +1.9 negative 0 +/- in % +15
MEDIAN 68.00 MEDIAN 2.90
Maximum 70.00 Maximum 3.05
Minimum 58.00 Minimum 2.73
Amount 7 Amount 5
Cheuvreux 63.00 Outperform 3.05
Credit Suisse 58.00 Neutral 2.75
Deutsche Bank 68.00 Buy 2.93
Exane BNP Paribas 69.00 Outperform 2.73
Helvea 64.00 Accumulate --
J.P. Morgan 70.00 Overweight --
Natixis 69.00 Buy 2.90
===
Year-earlier figures are as reported by the company.
DJG/err
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
July 19, 2012 11:22 ET (15:22 GMT)
Copyright (c) 2012 Dow Jones & Company, Inc.